Genome Data Systems, Inc. (GDS) is a biotechnology company with a focus on utilizing its proprietary technologies to manufacture and commercialize DNA and protein microarray products and innovative microfluidics systems for the genomics, proteomics and drug discovery markets. GDS technologies promise to revolutionize drug discovery research by reducing the cost and increasing the throughput of commonly used assays. Current projects include a cell-based assay system (GeneCardTM) for submicroliter analysis, and a novel proteomics analysis system (GeneCubeTM)
